Nagelschmitz J - Search Results

1

Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.

Becker-Pelster EM, Hahn MG, Delbeck M, Dietz L, Hüser J, Kopf J, Kraemer T, Marquardt T, Mondritzki T, Nagelschmitz J, Nikkho SM, Pires PV, Tinel H, Weimann G, Wunder F, Sandner P, Schuhmacher J, Stasch JP, Truebel HKF. Becker-Pelster EM, et al. Among authors: nagelschmitz j. Respir Res. 2022 Oct 1;23(1):272. doi: 10.1186/s12931-022-02189-1. Respir Res. 2022. PMID: 36183104 Free PMC article.

2

Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.

Stass H, Nagelschmitz J, Kappeler D, Sommerer K, Kietzig C, Weimann B. Stass H, et al. Among authors: nagelschmitz j. J Aerosol Med Pulm Drug Deliv. 2017 Feb;30(1):53-63. doi: 10.1089/jamp.2015.1282. Epub 2016 Jul 22. J Aerosol Med Pulm Drug Deliv. 2017. PMID: 27448179 Clinical Trial.

3

Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial.

Watz H, Nagelschmitz J, Kirsten A, Pedersen F, van der Mey D, Schwers S, Bandel TJ, Rabe KF. Watz H, et al. Among authors: nagelschmitz j. Pulm Pharmacol Ther. 2019 Jun;56:86-93. doi: 10.1016/j.pupt.2019.03.009. Epub 2019 Mar 24. Pulm Pharmacol Ther. 2019. PMID: 30917927 Clinical Trial.

4

Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals with Mild or Moderate Hepatic Impairment.

Heinig R, Lambelet M, Nagelschmitz J, Alatrach A, Halabi A. Heinig R, et al. Among authors: nagelschmitz j. Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):619-628. doi: 10.1007/s13318-019-00547-x. Eur J Drug Metab Pharmacokinet. 2019. PMID: 30825073

5

Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.

Stass H, Weimann B, Nagelschmitz J, Rolinck-Werninghaus C, Staab D. Stass H, et al. Among authors: nagelschmitz j. Clin Ther. 2013 Oct;35(10):1571-81. doi: 10.1016/j.clinthera.2013.08.003. Epub 2013 Sep 18. Clin Ther. 2013. PMID: 24054830 Free article. Clinical Trial.

6

Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study.

Stass H, Delesen H, Nagelschmitz J, Staab D. Stass H, et al. Among authors: nagelschmitz j. J Aerosol Med Pulm Drug Deliv. 2015 Apr;28(2):106-15. doi: 10.1089/jamp.2013.1056. Epub 2014 Jul 22. J Aerosol Med Pulm Drug Deliv. 2015. PMID: 25050456 Clinical Trial.

7

Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.

Stass H, Nagelschmitz J, Kappeler D, Sommerer K, Patzlaff A, Weimann B. Stass H, et al. Among authors: nagelschmitz j. J Aerosol Med Pulm Drug Deliv. 2019 Jun;32(3):156-163. doi: 10.1089/jamp.2018.1464. Epub 2019 Mar 8. J Aerosol Med Pulm Drug Deliv. 2019. PMID: 30848695 Clinical Trial.

8

Biopharmaceutical Characteristics of Nifurtimox Tablets for Age- and Body Weight-Adjusted Dosing in Patients With Chagas Disease.

Stass H, Feleder E, Garcia-Bournissen F, Nagelschmitz J, Weimann B, Yerino G, Altcheh J. Stass H, et al. Among authors: nagelschmitz j. Clin Pharmacol Drug Dev. 2021 May;10(5):542-555. doi: 10.1002/cpdd.871. Epub 2020 Oct 8. Clin Pharmacol Drug Dev. 2021. PMID: 33029953 Free PMC article. Clinical Trial.

9

Pharmacokinetics of moxifloxacin are not influenced by a 7-day pretreatment with 200 mg oral itraconazole given once a day in healthy subjects.

Stass H, Nagelschmitz J, Moeller JG, Delesen H. Stass H, et al. Among authors: nagelschmitz j. Int J Clin Pharmacol Ther. 2004 Jan;42(1):23-9. doi: 10.5414/cpp42023. Int J Clin Pharmacol Ther. 2004. PMID: 14756383 Clinical Trial.

10

Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study.

Stass H, Nagelschmitz J, Willmann S, Delesen H, Gupta A, Baumann S. Stass H, et al. Among authors: nagelschmitz j. Clin Drug Investig. 2013 Jun;33(6):419-27. doi: 10.1007/s40261-013-0082-0. Clin Drug Investig. 2013. PMID: 23605507 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters